Business · 14/05/1999Updated: 10/17/2026 · 1 min read
FDA Amends Biologics Regulations for Blood Derivative Products
Summary
The Food and Drug Administration (FDA) is updating its regulations for blood derivative products, including albumin, plasma protein fraction, and immune globulin, to align with current practices and eliminate unnecessary requirements, effective September 27, 1999.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →